汇添富香港优势精选混合(QDII)A

Search documents
前三季度主动权益类基金收益向好 诞生超过30只“翻倍基”
Shen Zhen Shang Bao· 2025-09-30 04:57
Group 1 - The overall performance of actively managed equity funds has been positive this year, with over 90% of funds reporting positive returns in the first three quarters, including 34 funds that have doubled their returns [1] - The average return of equity funds is 28.18%, while mixed funds average 25.88%. A total of 4,661 actively managed equity funds have reported positive returns, accounting for over 97% [1] - The top-performing fund, Yongying Technology Select Mixed Fund A, achieved a net value increase of 189.58%, surpassing the benchmark return by nearly 149 percentage points, with a total return of 228.38% since its inception [1] Group 2 - The leading funds are primarily focused on sectors such as technology, innovative pharmaceuticals, and the Beijing Stock Exchange, which have shown strong performance this year [2] - The A-share Technology 50 Index has risen by 34.47%, while the Hang Seng Technology Index has increased by nearly 41%. The A-share innovative pharmaceutical sector index has gained nearly 47%, and the North Exchange 50 Index has risen by 47.33% [2] - The fund manager of Yongying Technology Select Mixed Fund A highlighted a market environment characterized by confidence recovery and policy implementation, with a focus on global cutting-edge models, emerging applications, and investment opportunities in the global cloud computing industry [2]
主动权益类基金收益向好 前三季度诞生超过30只“翻倍基”
Sou Hu Cai Jing· 2025-09-29 04:23
Group 1 - The overall performance of actively managed equity funds has been positive this year, with over 90% of funds reporting positive returns in the first three quarters, including 34 funds that have doubled their returns [1][3] - The average return for actively managed equity funds is significantly higher than the overall average, with stock funds averaging 28.18% and mixed funds averaging 25.88% [1][3] - The top-performing funds are primarily focused on sectors such as technology, innovative pharmaceuticals, and the Beijing Stock Exchange, which have shown strong performance this year [3][4] Group 2 - The top fund, Yongying Technology Select Mixed Fund A, has achieved a net value increase of 189.58%, surpassing the benchmark return by nearly 149 percentage points [2][3] - Other notable funds include Huatai-PineBridge Hong Kong Advantage Select Mixed Fund A and China Europe Digital Economy Mixed Fund A, with returns of 152.25% and 135.06% respectively [2][3] - The A-share Technology 50 Index has risen by 34.47%, while the A-share innovative pharmaceutical index has increased by nearly 47%, indicating strong sector performance [3][4] Group 3 - Fund managers are optimistic about the market's recovery, focusing on global advancements in technology and the potential for growth in innovative pharmaceuticals [3][4] - The healthcare sector is expected to see a recovery in demand and behavior, with supportive policies for innovative pharmaceuticals anticipated to improve conditions in the coming years [4] - The North Exchange is expected to benefit from a new industrial cycle and the increasing presence of quality companies listing on the exchange [4]